Friday, October 14, 2011

Vitamin B2 (Riboflavin) and defective Gene ACAD9

Posted by Chantel M. Contributed by US National Library of Medicine National Institutes of Health

In the study of "Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene" by Gerards M, van den Bosch BJ, Danhauser K, Serre V, van Weeghel M, Wanders RJ, Nicolaes GA, Sluiter W, Schoonderwoerd K, Scholte HR, Prokisch H, Rötig A, de Coo IF, Smeets HJ., posted in US National Library of Medicine National Institutes of Health, researchers found that Our data support a new function for ACAD9 in complex I function, making this gene an important new candidate for patients with complex I deficiency, which could be improved by riboflavin treatment.

1 comment:

  1. more and more medicines are being recognized for improving alternative ailments other than what they were designed for. For instance they are saying now that the flu shot has a 20% chance of a person not to have an AMI.


    ReplyDelete